| 1 |
33222389 | Comparative Efficacy of Angiotensin II Type 1 Receptor Blockers Against Ventilator-Induced Diaphragm Dysfunction in Rats. | 2021 Mar |
1 |
| 2 |
33461698 | Irbesartan (a comprehensive profile). | 2021 |
1 |
| 3 |
33708834 | Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma. | 2021 Feb |
6 |
| 4 |
34620946 | Irbesartan, an angiotensin II type 1 receptor blocker, inhibits colitis-associated tumourigenesis by blocking the MCP-1/CCR2 pathway. | 2021 Oct 7 |
1 |
| 5 |
32983943 | Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity. | 2020 |
2 |
| 6 |
30865228 | PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy. | 2019 Sep 1 |
1 |
| 7 |
30405294 | Angiotensin II and the Natriuretic and Blood Pressure Response to Mental Stress in African Americans. | 2018 Fall |
1 |
| 8 |
27346437 | Long-term effects of angiotensin II blockade with irbesartan on inflammatory markers in hemodialysis patients: A randomized double blind placebo controlled trial (SAFIR study). | 2017 Jan |
1 |
| 9 |
27564102 | Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation. | 2016 Oct 11 |
2 |
| 10 |
27932705 | Possible role for glomerular-derived angiotensinogen in nephrotic syndrome. | 2016 Oct |
1 |
| 11 |
25423498 | Comparison of calycosin and irbesartan for their impact on renin angiotensin system in human umbilical vein endothelial cell. | 2015 Feb |
3 |
| 12 |
26030651 | Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study). | 2015 |
2 |
| 13 |
25551221 | Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance. | 2014 |
1 |
| 14 |
23743807 | Urinary renin and angiotensinogen in type 2 diabetes: added value beyond urinary albumin? | 2013 Aug |
2 |
| 15 |
21384133 | Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria. | 2012 May |
2 |
| 16 |
22388234 | An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trials. | 2012 May |
1 |
| 17 |
22426690 | Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling. | 2012 Jun |
1 |
| 18 |
22842919 | Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway. | 2012 Oct |
1 |
| 19 |
21236267 | Irbesartan inhibits advanced glycation end product (AGE)-induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) mRNA levels in glomerular endothelial cells. | 2011 May |
3 |
| 20 |
21609598 | [Production of connective tissue growth factor by angiotensin II in human embryonic lung fibroblast via RhoA-ROCK pathway]. | 2011 Apr 26 |
3 |
| 21 |
21949635 | Long-term use and tolerability of irbesartan for control of hypertension. | 2011 |
1 |
| 22 |
20663195 | Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells. | 2010 Jul 27 |
1 |
| 23 |
21949618 | Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination. | 2010 |
2 |
| 24 |
23781414 | A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazide. | 2010 Oct |
1 |
| 25 |
19795011 | Angiotensin blockade to reduce microvascular damage in diabetes mellitus. | 2009 Aug |
1 |
| 26 |
18227384 | Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression. | 2008 Feb 12 |
1 |
| 27 |
18422814 | Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study. | 2008 May |
1 |
| 28 |
18633426 | Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden. | 2008 Dec |
1 |
| 29 |
18666803 | Rationale for and design of the CREATIVE-AF trial: randomized, double-blind, placebo-controlled, crossover study of the effect of irbesartan on oxidative stress and adhesion molecules in patients with persistent atrial fibrillation. | 2008 |
2 |
| 30 |
18687761 | Irbesartan attenuates Ang II-induced BMP-2 expression in human umbilical vein endothelial cells. | 2008 Aug |
3 |
| 31 |
18993115 | Direct pro-arrhythmogenic effects of angiotensin II can be suppressed by AT1 receptor blockade in human atrial myocardium. | 2008 Dec |
2 |
| 32 |
17192509 | Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects. | 2007 Jan |
1 |
| 33 |
17444886 | Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study. | 2007 May |
1 |
| 34 |
17762662 | Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). | 2007 Sep |
1 |
| 35 |
16794485 | Carvedilol-induced antagonism of angiotensin II: a matter of alpha1-adrenoceptor blockade. | 2006 Jul |
1 |
| 36 |
15662225 | Enhanced angiotensin II-mediated effects in fibroblasts of patients with familial hypercholesterolemia. | 2005 Feb |
1 |
| 37 |
15749161 | Angiotensin II, angiotensin II antagonists and spironolactone and their modulation of cardiac repolarization. | 2005 Mar |
1 |
| 38 |
15761243 | Effect of high glucose on superoxide in human mesangial cells: role of angiotensin II. | 2005 |
2 |
| 39 |
15881846 | [Remodelling in atrial fibrillation]. | 2005 Apr |
1 |
| 40 |
15939823 | Association of osteoprotegerin with human abdominal aortic aneurysm progression. | 2005 Jun 14 |
1 |
| 41 |
16321381 | Effects of losartan and irbesartan administration on brain angiotensinogen mRNA levels. | 2005 Dec 28 |
1 |
| 42 |
14730203 | Role of reactive oxygen species-sensitive extracellular signal-regulated kinase pathway in angiotensin II-induced endothelin-1 gene expression in vascular endothelial cells. | 2004 Jan-Feb |
4 |
| 43 |
15109447 | Effect of irbesartan on angiotensin II-induced hypertrophy of human proximal tubular cells. | 2004 Apr |
1 |
| 44 |
15134586 | Signaling of angiotensin II-induced vascular protein synthesis in conduit and resistance arteries in vivo. | 2004 May 10 |
1 |
| 45 |
15167450 | Enhanced platelet release of superoxide anion in systemic hypertension: role of AT1 receptors. | 2004 Jun |
1 |
| 46 |
15614026 | Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment. | 2004 Dec |
1 |
| 47 |
12827025 | Functional comparison of the antagonistic properties of some Angiotensin II type 1 receptor blockers on the contraction elicited by Angiotensin II and thromboxane A2 on human saphenous veins. | 2003 Jul |
1 |
| 48 |
12969165 | Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood. | 2003 Oct |
1 |
| 49 |
13678427 | Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy. | 2003 Sep 18 |
1 |
| 50 |
14639093 | Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). | 2003 Dec |
2 |